An updated version of the Patient Decision Aid, a tool which will have undergone preliminary field testing with regional Canadian patient focus groups, will be presented, and this will be followed by open discussion. The session will: 1) raise awareness across the decision-making health community about recent drug regulatory science innovations driving a patient-focused approach; and 2) be a springboard to trigger further engineering of applications for these trends for use across the community.